Pain Relief Patches Market Size, Share, and Growth Forecast from 2025 - 2032

Pain Relief Patches Market by Product Type (Non-steroidal Anti-inflammatory Drug Patches, Opioid Patches, Local Anesthetic Patches), Indication (Menstrual Cramps, Orthopedic Pain), Distribution Channel (Hospital Pharmacies), and Regional Analysis from 2025 to 2032

Industry: Healthcare

Published Date: January-2025

Format: PPT*, PDF, EXCEL

Delivery Timelines: Contact Sales

Number of Pages: 250

Report ID: PMRREP33349

Report Price

$ 4995*

Buy Now

Pain Relief Patches Market Size and Share Analysis

The global pain relief patches market is predicted to reach a size of US$ 4.1 Bn by 2025. It is anticipated to showcase a CAGR of 5.7% during the forecast period to attain a value of US$ 6 Bn by 2032.

Chronic pain, especially musculoskeletal and neuropathic pain, is becoming prevalent owing to the aging population, sedentary lifestyles, and rising rates of obesity. This trend is predicted to drive the demand for effective pain relief solutions like pain relief patches.

  • According to the Centers for Disease Control and Prevention (CDC), an estimated 50 million adults in the U.S. suffer from chronic pain, and more than 20 million experience high-impact chronic pain.

Pain relief patches provide a non-addictive, localized, and effective solution for managing both acute and chronic pain. The opioid crisis, especially in the U.S. has led to a significant decline in the prescription of opioid painkillers. Consumers and healthcare providers are turning to alternative pain relief methods, like non-opioid topical treatments.

  • Use of non-opioid pain relief products is predicted to increase by 35% over the next decade, driving demand for products like pain relief patches.

pain relief patches market outlook, 2019-2032

Key Highlights of the Industry

  • Advances in transdermal drug delivery technology have led to the formation of effective, safer, and longer-lasting pain relief patches.
  • Companies are using unique formulations and permeation enhancers to improve the patch's ability to deliver medications efficiently through the skin barrier.
  • Increasing awareness about the benefits of using patches for localized pain relief has led to greater consumer demand.
  • Growing availability of pain relief patches in pharmacies, online platforms, and through direct-to-consumer channels is fueling growth.
  • Capsaicin patches are estimated to exhibit a CAGR of 6.7% through 2032
  • Next generation of pain relief patches is predicted to be more sophisticated, offering longer wear times, effective drug release mechanisms, and higher precision in drug delivery.
  • Some patches are also incorporating wearable technology to monitor and adjust the delivery of medication in real time.
  • Based on product type, the non-steroidal anti-inflammatory drug patches segment is likely to hold a share of 40% in 2025 owing to their ability to provide targeted relief.
  • In terms of indication, the menstrual cramps segment is predicted to hold a share of 29% in 2025 owing to the need to convenient and discreet pain relief alternatives.
  • North America pain relief patches market is likely to witness a CAGR of 5.4% through 2032.

Market Attributes

Key Insights

Pain Relief Patches Market Size (2025E)

US$ 4.1 Bn

Projected Market Value (2032F)

US$ 6 Bn

Global Market Growth Rate (CAGR 2025 to 2032)

5.7%

Historical Market Growth Rate (CAGR 2019 to 2023)

4.6%

Awareness of the Benefits of Topical Pain Relief Treatments to Boost North America

North America pain relief patches market is estimated to hold a share of 50% in 2025. Opioid crisis in North America, especially in the U.S., has led to a significant push for non-opioid alternatives for pain management. Pain relief patches, which provide localized relief without the risks of addiction or side effects associated with oral opioids, have gained significant traction.

  • The CDC reported that opioids were involved in nearly 70% of all drug overdose deaths in 2020 in the U.S., highlighting the growing need for safer, non-addictive pain management options. This has increased the adoption of alternatives like pain relief patches.

Consumers in the region are becoming increasingly aware regarding the benefits of topical pain relief treatments. Growing awareness of pain management options, including patches that deliver active ingredients directly to the source of pain, is driving demand.

  • A 2019 survey conducted by Ipsos indicated that nearly 60% of American adults have used some form of topical pain relief treatment, including patches, to manage pain.

NSAID Patches are Gaining Traction Owing to Ability to Provide Targeted Relief

Non-steroidal anti-inflammatory drug (NSAID) patches are anticipated to hold a share of 40% in 2025. NSAID patches are increasingly preferred by consumers and healthcare professionals for managing conditions like arthritis, musculoskeletal pain, and post-surgical pain. This popularity is attributed to their ability to provide targeted relief for pain at the site of application, delivering the active ingredients directly to the pain source.

  • According to a 2021 study published in the Journal of Pain Research, NSAID patches were shown to deliver more targeted pain relief with fewer gastrointestinal side effects compared to oral NSAIDs.

NSAID patches are a non-invasive and easy-to-use alternative to oral medications and other forms of pain relief like injections or physical therapies. This convenience is driving their popularity, especially in the self-care segment.

Pain Relief Patches Offer a Convenient and Discreet Alternative for Menstrual Cramps

Menstrual cramps are anticipated to hold a share of 29% in 2025. Studies indicate that a large proportion of women suffer from menstrual pain, making it a key driver for the pain relief patches market.

  • According to the American College of Obstetricians and Gynecologists (ACOG), 50% to 90% of women report experiencing menstrual cramps at some point in their lives. Around 15% to 20% of these women experience severe pain that interferes with daily activities, creating a significant market for effective pain relief solutions like patches.

Several women prefer non-invasive, over-the-counter (OTC) solutions for managing menstrual cramps. Pain relief patches, especially those that deliver heat or NSAIDs typically, offer a convenient and discreet alternative to oral medications.

  • A 2020 survey found that 40% of women in the U.S. prefer using non-pharmaceutical pain relief methods for menstrual cramps owing to concerns about the side effects of oral pain relievers.

Heat therapy is particularly effective in alleviating menstrual cramps by relaxing the muscles in the abdominal area, while NSAID patches provide anti-inflammatory benefits. Recent advancements in the formulation and design of pain relief patches have made them more effective and comfortable for users. Some patches for menstrual cramps combine heat therapy with natural ingredients, providing additional soothing effects, leading to increased adoption.

Market Introduction and Trend Analysis

Potential growth in the global pain relief patches industry is predicted to be driven by technological advancements, including smart patches capable of monitoring pain levels and delivering real-time relief. Increasing focus on non-invasive solutions for menstrual pain is predicted to continue driving growth. Integration of telehealth and wearable technology with pain relief patches like apps that track pain levels and adjust the medication dosage are likely to contribute to evolution.

India aluminum beverage can market insights and key trends

Historical Growth and Course Ahead

The pain relief patches market growth was decent at a CAGR of 4.6% during the historical period. The period witnessed a demand for topical pain relief solutions owing to increasing awareness regarding alternatives for oral medications and concerns over the side effects of conventional painkillers.

During the COVID-19 pandemic, people increasingly turned to at-home treatment options for managing chronic pain due to restrictions on visits to healthcare facilities, thereby fostering growth in the market.

  • Heat therapy and NSAID patches became particularly popular, contributing to a rise in value to US$ 6.2 billion in 2020.

Adoption of non-steroidal anti-inflammatory drug (NSAID) patches and menthol-based patches continued to rise. This growth was attributed to their efficacy in providing targeted relief without the need for oral medications.

The forecast period is estimated to witness advanced pain relief patches with sustained-release mechanisms, combination therapies, and herbal/organic formulations. This results in effective and comfortable solutions for consumers. Rise of health-conscious lifestyles along with increased focus on holistic well-being are promoting the use of natural and safe remedies like topical patches.

Market Growth Drivers

Convenience and Ease of Use

Pain relief patches are typically designed to be applied directly to the affected area, requiring minimal effort from users. They are self-adhesive, enabling consumers to easily place them on the skin and wear them throughout the day or night. This simplicity makes them particularly attractive to individuals looking for a quick and hassle-free solution to manage pain without requiring special skills or professional help.

  • Research has shown that 85% of consumers prefer using patches for localized pain relief due to their ease of application and ability to be worn discreetly under clothing.

Several pain relief patches are thin and clear, making them invisible when worn under clothing. This is ideal for individuals who want to manage their pain without drawing attention to the product they are using. This discreet nature adds to their appeal, particularly for those seeking solutions that won't interfere with their daily lives.

Pain relief patches often provide sustained and continuous pain relief over an extended period depending on the product. The slow-release mechanism of active ingredients ensures that users experience relief without needing to reapply frequently or take oral medications multiple times a day.

  • A survey revealed that 72% of users report satisfaction with the long-lasting effects of pain relief patches.

Increasing Awareness and Acceptance of Self-care

The healthcare industry is witnessing a shift as consumers are taking more responsibility for their own health. People are more informed and proactive about managing their wellness, resulting in a greater focus on self-care, including pain management. Increased acceptance of home-based treatments has encouraged people to seek solutions like pain relief patches.

  • According to a survey by the Global Wellness Institute, 59% of consumers globally reported using some form of self-care product regularly, with pain relief patches being one of the most common solutions for managing everyday pain.

Rise in self-care is supported by various educational campaigns from manufacturers and healthcare professionals. These campaigns highlight the benefits of pain relief patches, focusing on their ease of use, effectiveness, and ability to deliver localized relief without the need for oral medication.

  • A study revealed that 47% of consumers mentioned they became more interested in over-the-counter pain relief solutions like patches after seeing informative content about their benefits.

Market Restraining Factors

Environmental Impact of Disposable Patches

Pain relief patches, particularly those that are disposable, contribute to significant waste generation. Increasing consumption of single-use patches, along with the plastic materials used in their production, exacerbates this issue.

  • A 2019 report by the World Economic Forum estimated that by 2050, there could be more plastic in the ocean than fish by weight, largely driven by single-use plastics like those used in medical products, including patches.

Several pain relief patches contain plastic-based materials in their adhesive backing, as well as active pharmaceutical ingredients embedded in polymers. These materials are not biodegradable, and their improper disposal could lead to long-term environmental degradation.

  • According to a 2020 report by Greenpeace, approximately 80% of all plastic used in medical products, including disposable patches, does not break down naturally, contributing to persistent waste in landfills and ecosystems.

Market Growth Opportunities

Shift toward Non-invasive Treatments

As consumers become aware of the risks and complications associated with invasive treatments, there is a growing preference for non-invasive pain management solutions like topical patches. Non-invasive treatments are perceived to be safer, convenient, and easy to use.

  • The National Institute on Drug Abuse (NIDA) noted the consumer shift toward non-addictive and non-invasive alternatives with 31% of consumers actively seeking opioid-free pain relief options.

Pain relief patches offer the convenience of home use, enabling consumers to manage their pain without needing to visit healthcare facilities. Patches can be applied easily and discreetly, providing targeted relief without the need for special equipment or healthcare providers.

  • A survey revealed that 45% of consumers prefer to manage their pain at home with over-the-counter, non-invasive treatments like pain relief patches, highlighting the demand for self-managed, home-based pain relief solutions.

Preference for Over-the-counter (OTC) Solutions

OTC pain relief patches are easily available at pharmacies, supermarkets, and even online platforms, making them highly accessible to consumers. This ease of access has contributed to the widespread adoption of pain relief patches.

  • According to a 2019 survey by the Consumer Healthcare Products Association (CHPA), 70% of adults in the U.S. prefer to treat minor ailments like pain and inflammation with OTC products, and approximately 50% of consumers report using OTC pain relief patches as part of their self-care regimen.

OTC pain relief patches are a cost-effective option for individuals seeking pain relief without incurring high medical expenses. As more people embrace self-care practices, OTC products like pain relief patches are becoming increasingly popular.

  • A 2021 report revealed that 44% of U.S. adults prefer to use OTC medications for managing pain, compared to only 17% who opt for prescription treatments.

Competitive Landscape for the Pain Relief Patches Market

Companies in the pain relief patches market are investing in research and development to improve the effectiveness, comfort, and duration of pain relief patches. This includes the development of advanced formulation that provide long lasting relief, enhanced adhesion, and better skin compatibility.

A few manufacturers are incorporating non-steroidal anti-inflammatory drugs (NSAIDs) in their patches to target specific pain relief. They are also adding herbal or natural ingredients to appeal to consumers looking for alternative treatments.

Businesses are focusing on expanding in emerging markets as they are witnessing a rise in healthcare access. They are also progressively partnering with healthcare providers, distributors, and ecommerce platforms to expand their reach.

Recent Industry Developments

  • In December 2024, Tenable announced the release of Tenable Patch Management, a autonomous patch solutions developed through a strategic partnership with Adaptiva.
  • In October 2024, Tonik launched transdermal patches formulated with homeopathic reciepes for sleep and stress relief in some Asian markets.
  • In April 2024, Hisamitsu Pharmaceutical Co. Inc., introduced Salonpas pain patch, a innovative solution for pain management in Nigeria.
  • In October 2023, Nysh.in announced the launch of “Cramp Care” pain relief patch under the BluHeat Category.
  • In July 2023, Industrial Macchine Automatiche S.P.A. (IMA), based in Italy, acquired a 60% stake in Phoenix Italia S.r.l. and full ownership of its subsidiary, Phoenix Tech S.r.l. Both companies, located in Bareggio (Milano), were purchased from their sole shareholder, Phoenix Group Holding S.r.l.

Pain Relief Patches Market Report Scope

Attributes

Detail

Forecast Period

2025 to 2032

Historical Data Available for

2019 to 2023

Market Analysis

US$ Billion for Value

Key Regions Covered

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Key Market Segments Covered

  • Product Type
  • Indication
  • Distribution Channel
  • Region

Key Companies Profiled in the Report

 
  • Viatris, Inc. (Mylan)
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Hisamitsu Pharmaceutical Co., Inc.
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Nichiban Co., Ltd.
  • Teikoku Seiyaku Co, Ltd.
  • Mentholatum Company
  • Purdue Pharma L.P.
  • West-Ward Pharmaceuticals Corporation
  • Pfizer, Inc
  • Allergan PLC (Actavis)
  • Endo International PLC
  • Mylan N.V.
  • Corium, Inc.
  • Agile Therapeutics Inc.

Report Coverage

  • Market Forecast and Trends
  • Company Share Analysis
  • Competitive Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives  

Customization and Pricing

Available upon request

Market Segmentation

By Product Type

  • Non-steroidal Anti-inflammatory Drug Patches
    • Ketoprofen Patches
    • Diclofenac Patches
    • Flurbiprofen Patches
    • Piroxicam Patches
  • Opioid Patches
    • Fentanyl Patches
    • Buprenorphine Patches
  • Local Anesthetic Patches
    • Nitroglycerine Patches
    • Capsaicin Patches
    • Lidocaine Patches

By Indication

  • Menstrual Cramps
  • Orthopedic Pain
  • Neuropathic Pain
  • Post-operative Pain
  • Cardiovascular Pain
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa

To know more about delivery timeline for this report Contact Sales

Companies Covered in This Report

  • Viatris, Inc. (Mylan)
  • Johnson & Johnson Services, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi S.A.
  • Hisamitsu Pharmaceutical Co., Inc.
  • GlaxoSmithKline Plc.
  • Novartis AG
  • Nichiban Co., Ltd.
  • Teikoku Seiyaku Co, Ltd.
  • Mentholatum Company
  • Purdue Pharma L.P.
  • West-Ward Pharmaceuticals Corporation
  • Pfizer, Inc
  • Allergan PLC (Actavis)
  • Endo International PLC
  • Mylan N.V.
  • Corium, Inc.
  • Agile Therapeutics Inc.

Frequently Asked Questions

The market is anticipated to reach a value of US$ 6 Bn by 2032.

Non-steroidal anti-inflammatory drug patches are predicted to hold a share of 40% in 2025.

North America is anticipated to emerge as the leading region with a share of 50% in 2025.

Prominent players in the market include Viatris, Inc. (Mylan), Johnson & Johnson Services, Inc., and Teva Pharmaceutical Industries Ltd.

The market is predicted to witness a CAGR of 5.7% throughout the forecast period.

Thank you for taking time to visit our website, click like if you found the information on this page useful?

This site uses cookies, including third-party cookies, that help us to provide and improve our services.
Google translate